Validation of mega composite sampling and nationwide mass inventories for 26 previously unmonitored contaminants in archived biosolids from the U.S National Biosolids Repository

Water Research

Volumn 46, Issue 15, 2012, Pages 4814-4824

  Chari, Bipin P ^a   Halden, Rolf U ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Biosolids; Half life; Persistence; Pharmaceuticals; PPCPs; Risk assessment

Indexed keywords

BIOLOGICAL MATERIALS; BIOSOLIDS; DRUG PRODUCTS; ENVIRONMENTAL PROTECTION AGENCY; SEWAGE SLUDGE; SOILS; WASTEWATER TREATMENT;

ANALYTES; COMPOSITE SAMPLING; HALF LIVES; MASS INVENTORY; PERSISTENCE; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; RISKS ASSESSMENTS; U.S. ENVIRONMENTAL PROTECTION AGENCY; US ENVIRONMENTAL PROTECTION AGENCY; WASTE WATER TREATMENT PLANTS;

RISK ASSESSMENT;

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

AGRICULTURAL SOIL; BIOSOLID; CALCIUM; DRUG; POLLUTION EFFECT; SAMPLING; SEWAGE; SEWAGE TREATMENT; SLUDGE; SOIL POLLUTION;

ARTICLE; BIOSOLID; ELECTROSPRAY MASS SPECTROMETRY; MESOCOSM; PRIORITY JOURNAL; RISK ASSESSMENT; SOIL POLLUTION; UNITED STATES; WASTE WATER TREATMENT PLANT; WATER ANALYSIS;

UNITED STATES;

EID: 84864031198     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2012.06.017     Document Type: Article

References (52)

1. Barnes K.K., Christenson S.C., Kolpin D.W., Focazio M.J., Furlong E.T., Zaugg S.D., Meyer M.T., Barber L.B. Pharmaceuticals and other organic wastewater contaminants within a leachate plume downgradient of a municipal landfill. Ground Water Monitoring and Remediation 2004, 24(2):119-126.
2. Barron L. Occurrence and Fate of Pharmaceuticals and Personal Care Products within Sewage Sludge and Sludge-enriched Soils: Summary of Findings 2009, Dublin City University, Norwegian Institute for Water Research (NIVA), and Masaryk University, Czech Republic, Dublin, Ireland, 3 pp; available:. http://www.epa.ie/downloads/pubs/research/waste/STRIVE_34_PPCPs_Summary_Findings.pdf.
3. Bartelt-Hunt S.L., Snow D.D., Damon T., Shockley J., Hoagland K. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environmental Pollution 2009, 157(3):786-791.
4. Batt A.L., Kostich M.S., Lazorchak J.M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Analytical Chemistry 2008, 80(13):5021-5030.
5. Bendz D., Paxeus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. Journal of Hazardous Materials 2005, 122(3):195-204.
6. Bound J.P., Voulvoulis N. Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environmental Health Perspectives 2005, 113(12):1705-1711.
7. Castiglioni S., Baganti R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environmental Science & Technology 2006, 40(1):357-363.
8. Chiaia A.C., Banta-Green C., Field J. Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in U.S. wastewaters. Environmental Science & Technology 2008, 42(23):8841-8848.
9. Chu S., Metcalfe C.D. Analysis of paroxetine, fluoxetine, and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography - tandem mass spectrometry. Journal of Chromatography A 2007, 1163(1-2):112-118.
10. Daughton C.G. Illicit drugs: contaminants in the environment and utility in forensic epidemiology. Reviews of Environmental Contamination and Toxicology 2011, 210:59-110.
11. De Lannoy G.J.M., Verhoest N.E.C., Houser P.R., Gish T.J., Van Meirvenne M. Spatial and temporal characteristics of soil moisture in an intensively monitored agricultural field (OPE3). Journal of Hydrology 2006, 331(3-4):719-730.
12. Eggen T., Moeder M., Arukwe A. Municipal landfill leachates: a significant source for new and emerging pollutants. Science of the Total Environment 2010, 408(21):5147-5157.
13. Gobel A., Thomsen A., Mcardell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environmental Science & Technology 2005, 39(11):3981-3989.
14. Gonzáles-Mariño I., Quintana J.B., Rodriguez I., Cela R. Determination of drugs of abuse in water by solid-phase extraction, derivatisation and gas chromatography-ion trap-tandem mass spectrometry. Journal of Chromatography A 2010, 1217(11):1748-1760.
15. Gottschall N., Topp E., Metcalfe C., Edwards M., Payne M., Kleywegt S., Russell P., Lapen D.R. Pharmaceutical and personal care products in groundwater, subsurface drainage, soil, and wheat grain, following a high single application of municipal biosolids to a field. Chemosphere 2012, Jan 31. [Epub ahead of print].
16. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lutzhoft H.C.H., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36(2):357-394.
17. Heidler J., Halden R.U. Mass balance assessment of triclosan removal during conventional sewage treatment. Chemosphere 2007, 66(2):362-369.
18. Higgins C.P., McLeod P.B., MacManus-Spencer L.A., Luthy R.G. Bioaccumulation of perfluorochemicals in sediments by the aquatic oligochaete Lumbriculus variegatus. Environmental Science & Technology 2007, 41(13):4600-4606.
19. Howard P.H., Muir D.C.G. Identifying new persistent and bioaccumulative organics among chemicals in commerce. Environmental Science & Technology 2010, 44(7):2277-2285.
20. Huerta-Fontela M., Galceran M.T., Ventura F. Ultraperformance liquid chromatography-tandem mass spectrometry analysis of stimulatory drugs of abuse in wastewater and surface waters. Analytical Chemistry 2007, 79(10):3821-3829.
21. Hummel D., Löffler D., Fink D., Ternes T.A. Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environmental Science & Technology 2006, 40(23):7321-7328.
22. IMS Health, 2009. http://www.rxlist.com/script/main/hp.asp.
23. Jelic A., Gros M., Ginebreda A., Cespedes-Sánchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Research 2011, 45(3):1165-1176.
24. Jones-Lepp T.L., Stevens R. Pharmaceuticals and personal care products in biosolids/sewage sludge: the interface between analytical chemistry and regulation. Analytical and Bioanalytical Chemistry 2007, 387(4):1173-1183.
25. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Research 2008, 42(13):3498-3518.
26. Kinney C.A., Furlong E.T., Zaugg S.D., Burkhardt M.R., Werner S.L., Cahill J.D., Jorgensen G.R. Survey of organic wastewater contaminants in biosolids destined for land application. Environmental Science & Technology 2006, 40(23):7207-7215.
27. Kinney C.A., Furlong E.T., Kolpin D.W., Burkhardt M.R., Zaugg S.D., Werner S.L., Bossio J.P., Benotti M.J. Bioaccumulation of pharmaceuticals and other anthropogenic waste indicators in earthworms from agricultural soil amended with biosolid or swine manure. Environmental Science & Technology 2008, 42(6):1863-1870.
28. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams 1999-2000: a national reconnaissance. Environmental Science & Technology 2002, 36(6):1202-1211.
29. Langdon K.A., Warne M.S.t.J., Kookana R.S. Aquatic hazard assessment for pharmaceuticals, personal care products, and endocrine-disrupting compounds from biosolids-amended land. Integrated Environmental Assessment and Management 2010, 6(4):663-676.
30. Lapen D.R., Topp E., Metcalfe C.D., Lic H., Edwards M., Gottschall N., Bolton P., Curnoed W., Payne M., Beck A. Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids. Science of the Total Environment 2008, 399(1-3):52-59.
31. McClellan K., Halden R.U. Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA national sewage sludge survey. Water Research 2010, 44(2):658-668.
32. Miao X.S., Metcalfe C.D. Determination of pharmaceuticals in aqueous samples using positive- and negative-voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometry. Journal of Mass Spectrometry 2003, 38(1):27-34.
33. Nagarnaik P., Batt A., Boulanger B. Concentrations and mass loadings of cardiovascular pharmaceuticals in healthcare facility wastewaters. Journal of Environmental Monitoring 2010, 12(11):2112-2119.
34. North East Biosolids and Residuals Association A National Biosolids Regulation, Quality, End Use & Disposal Survey 2007.
35. Postigo C., López de Alda M.J., Barceló D. Drugs of abuse and their metabolites in the Ebro River basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation. Environment International 2010, 36(1):75-84.
36. Phillips P.J., Smith S.G., Kolpin D.W., Zaugg S.D., Buxton H.T., Furlong E.T., Esposito K., Stinson B. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater-treatment-plant effluents. Environmental Science & Technology 2010, 44(13):4910-4916.
37. Radjenović J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Research 2009, 43(3):831-841.
38. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., Wathen J.B., Snyder B.D., Pitt J.L., Perez-Hurtado P., Dobbins L.L., Brooks B.W., Chambliss C.K. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environmental Toxicology and Chemistry 2009, 28(12):2587-2597.
39. Richards S.M., Cole S.E. A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology 2006, 15(8):647-656.
40. Scheurer M., Ramil M., Metcalfe C.D., Groh S., Ternes T.A. The challenge of analyzing beta-blocker drugs in sludge and wastewater. Analytical and Bioanalytical Chemistry 2010, 396(2):845-856.
41. Schultz M.M., Higgins C.P., Huset C.A., Luthy R.G., Barofsky D.F., Field J.A. Fluorochemical mass flows in a municipal wastewater treatment facility. Environmental Science & Technology 2006, 40(23):7350-7357.
42. Schultz M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in environmental aquatic matrices by LC/ESI/MS/MS. Analytical Chemistry 2008, 80(5):1756-1762.
43. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Research 1998, 32(11):3245-3260.
44. Ternes T.A., Bonerz M., Herrmann N., Teiser B., Andersen H.R. Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances. Chemosphere 2007, 66(5):894-904.
45. Topp E., Monteiro S.C., Beck A., Coelho B.B., Boxall A.B.A., Duenk P.W., Kleywegt S., Lapen D.R., Payne M., Sabourin L., Li H.X., Metcalfe C.D. Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Science of the Total Environment 2008, 396(1):52-59.
46. Trenholm R.A., Vanderford B.J., Holady J.C., Rexing D.J., Snyder S.A. Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 2006, 65(11):1990-1998.
47. USEPA Method 1694: Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS Washington, D.C 2007, EPA-821-R-08-002.
48. USEPA Sewage Sludge Use and Disposal Rule (40 CFR Part 503) - Fact Sheet 1992, U.S. Environmental Protection Agency, Washington, DC, EPA-882-F-92-002. Office of Water, Fact Sheet WH-556.
49. Walters E., McClellan K., Halden R.U. Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms. Water Research 2010, 44(20):6011-6020.
50. Williams R.T., Cook J.C. Exposure to pharmaceuticals present in the environment. Drug Information Journal 2007, 41(2):133-141.
51. Wu C.X., Witter J.D., Spongberg A.L., Czakowski K.P. Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin. Water Research 2009, 43(14):3407-3416.
52. Wu C.X., Spongberg A.L., Witter J.D., Fang M., Ames A., Czajkowlski K.P. Detection of pharmaceuticals and personal care products in agricultural soils receiving biosolids application. Clean-Soil Air Water 2010, 8(3):230-237.